In-depth articles on medical marijuana applications, prescriptions, and patient experiences.
10 articles in this category
Epilepsy is the one area where a cannabis compound became an approved prescription drug. The approval is narrower than most people assume, and it is CBD rather than cannabis.
Cannabis genuinely lowers intraocular pressure. It is still not a glaucoma treatment, and the reason is a matter of arithmetic rather than politics.
PTSD is among the most common qualifying conditions for medical cannabis. It is also one where the controlled evidence has repeatedly failed to match patient expectation.
Cannabis has genuinely strong evidence in cancer care, and it is all about symptoms. The cure claims rest on cell cultures, and there is one interaction oncologists want you to know about.
Multiple sclerosis spasticity is where cannabinoids have their clearest neurological approval. The interesting wrinkle is that patients and measuring instruments do not agree on how well it works.
The basal ganglia are full of CB1 receptors, which makes cannabis for Parkinson's an obvious idea. Controlled trials have not shown motor improvement, and the honest case is for secondary symptoms.
Cannabis trials in Crohn's disease produced a genuinely awkward result: patients felt considerably better while objective markers of inflammation barely moved.
Cannabis in children means two separate things: a narrow, real, prescription use in severe epilepsy, and a sharp rise in toddlers eating edibles that look like sweets.
Most cannabis risk discussion assumes decades of future exposure. In palliative care that assumption does not hold, and the risk-benefit balance genuinely shifts.
Medical marijuana is used to treat chronic pain, epilepsy, PTSD, and other conditions. Learn about qualifying conditions, how to get a card, and what to expect.